PCM
HTGM

Prelude Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Prelude Capital Management’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$106K Buy
2019
Q2 		$191K Buy
2019
Q1 		$130K Buy
2018
Q4 		$128K Buy
2018
Q3 		$132K Sell
2018
Q2 		$97K Buy